Singapore: US-based CytRx, a biopharmaceutical R&D company specializing in oncology, reached an agreement with the U...
Singapore: China based Zai Lab, an innovative biopharmaceutical company, has secured over $100 million in Series B finan...
Singapore: Australian company CSL Behring has submitted a variation application to the European Medicines Agency (EMA) f...
Singapore: Taiwan company Orient Europharma and Japan-based pharmaceutical company NanoCarrier have signed a new agreeme...
US-Australian drug discovery company, Novogen Limited has provided an update on progress regarding the development of Ca...
Tokyo: Toxoplasma gondii is a common parasite which causes the development of fatal encephalosis or pneumonia in immunod...
Tokyo: Gordagen Pharmaceuticals, an Australian company developing evidence-based nutraceuticals and pharmaceuticals, has...
Takeda Pharmaceutical Company Limited has announced that the Japanese Ministry of Health, Labour and Welfare has approve...
Singapore: Researchers at the Centre for Vision Research from the Westmead Millennium Institute for Medical Research (WM...
Singapore: The Systems Toxicology Computational Challenge run under the sbv IMPROVER umbrella, a crowdsourcing initiativ...
A Japanese delegation will initiate a partnership with University of Dundee seeking to develop new treatments for inflam...
Singapore: US Food and Drug Administration has approved Eli Lilly's ramucirumab (Cyramza) for use in combination with Fo...
Singapore: Scientists at A*Star's Institute of Medical Biology (IMB) and Institute of Molecular and Cellular Biology (IM...
Lung cancer occurs in two types, small cell lung cancer and the more prevalent non-small scale lung cancer. According to...
Singapore: Santaris Pharma, a privately held biopharmaceutical company focused on developing medicines targeted to disea...
Singapore: Japanese company Mitsubishi Tanabe has received approval to manufacture and market the selective DPP-4 inhibi...
Singapore: Addressing shareholders in the company's annual report, Indian drugmaker Wockhardt said that the company plan...
Sosei Group Corporation has reported that Heptares Therapeutics, the wholly-owned subsidiary of Japan's Sosei Group Corp...
Singapore: US Food and Drug Administration (FDA) has warned against type 2 diabetes medicine, canagliflozin (Invokana, I...
Singapore: Australia-based Drawbridge Pharmaceuticals has been granted patent for its anesthetic formulation Phaxan in t...
Singapore: Australia based TransBio and DendroCyte BioTech have entered into a multi-year collaboration to discover and ...
Singapore: Japanese drug major Daiichi Sankyo submitted a New Drug Application to the Ministry of Health, Labor and Welf...
Singapore: Orient EuroPharma, a specialty pharmaceutical company focused in marketing and commercialization has partnere...
Singapore: Innate Immunotherapeutics has raised $8.9 million (AUD10 million) through its Initial Public Offer (IPO) that...
Singapore: With an eye on advanced markets like US and Europe, India's Cadila Healthcare has said that it would soon sta...
